Remove Trends Regulations-Legislation-Enforcement
article thumbnail

WCG Clinical Announces Relaunch of FDAnews as the Premier Source for Drug and Device Insights

WCG Clinical

Media Contact: Carmin Gade Chief Marketing Officer, WCG 484.351.9959 cgade@wcgclinical.com About WCG FDAnews : WCG FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency.

article thumbnail

Informa Connect’s Coupon & Copay

Drug Channels

Benefit from crucial and timely updates addressing access challenges and exploring the impact of copay accumulators, maximizers and drug pricing legislation on patient affordability. Analyze State and Federal Progress Regulating Copay Programs DOJ Updates:?Government 2021 is a must-attend.

Drugs 40
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

A Final LDT Rule in April!? Will FDA be prepared?

FDA Law Blog

1] Yet FDA’s conclusions about the Agency’s ability to regulate the entire laboratory industry are based on fundamentally flawed assumptions about the number of entities and tests that will be subject to FDA regulation. 5] This stratification, though, assumes that LDTs will follow the same pattern as IVDs currently regulated by FDA.

article thumbnail

PFIZER REPORTS STRONG FIRST-QUARTER 2021 RESULTS

The Pharma Data

Although exchange rate changes are part of Pfizer’s business, they are not within Pfizer’s control and since they can mask positive or negative trends in the business, Pfizer believes presenting operational variances excluding these foreign exchange changes provides useful information to evaluate Pfizer’s results. (7)

article thumbnail

Illegal online pharmacies gain traction as regulators lag behind

Pharmaceutical Technology

In recent US Senate hearings, US legislators have raised concerns that these savings due to negotiations by pharmacy benefit managers (PBMs) have not been transferred to the end consumer, but rather to the PBMs themselves. GlobalData’s expansive report examines the business environment and trends that shape the Biopharmaceutical industry.

Pharmacy 130
article thumbnail

COVID-19 Pandemic Coverage

XTalks

Continuing trends suggest the worst may be over provided the outbreak is contained over the next few months. Meanwhile, N95 masks are in such short supply that regulators have told healthcare workers they can be used multiple times with little evidence that disinfecting them works. Economic Impact: Canada. Retail sales dropped by 16.4